| PERIOD ENDING | 30-Apr-09 | 31-Dec-08 | 31-Dec-07 | | Total Revenue | 2,996 | 2,186 | 2,891 | | Cost of Revenue | 122 | 304 | 293 | | | Gross Profit | 2,874 | 1,882 | 2,597 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 22 | 72 | 105 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 2,852 | 1,810 | 2,493 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (220) | (6,765) | (1,991) | | Earnings Before Interest And Taxes | 540 | 1,810 | 2,007 | | Interest Expense |
-
| 8 |
-
| | Income Before Tax | 540 | 1,802 | 2,007 | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,632 | (4,963) | 501 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 2,632 | (4,963) | 501 | | Preferred Stock And Other Adjustments | (43) | (574) | (618) | | | Net Income Applicable To Common Shares | $2,589 | ($5,537) | ($117) |
|
0.51% Nasdaq 
0.22 (1.72%) 
Income Statement
